Seguir
Lykke Pedersen
Lykke Pedersen
Abzu
Dirección de correo verificada de abzu.ai
Título
Citado por
Citado por
Año
Cell motility as random motion: A review
D Selmeczi, L Li, LII Pedersen, SF Nrrelykke, PH Hagedorn, S Mosler, ...
The European Physical Journal-Special Topics 157 (1), 1-15, 2008
1562008
Modeling oscillatory control in NF-κB, p53 and Wnt signaling
B Mengel, A Hunziker, L Pedersen, A Trusina, MH Jensen, S Krishna
Current opinion in genetics & development 20 (6), 656-664, 2010
782010
PAPD5/7 are host factors that are required for hepatitis B virus RNA stabilization
H Mueller, A Lopez, P Tropberger, S Wildum, J Schmaler, L Pedersen, ...
Hepatology 69 (4), 1398-1411, 2019
692019
Liver-targeted anti-HBV single-stranded oligonucleotides with locked nucleic acid potently reduce HBV gene expression in vivo
H Javanbakht, H Mueller, J Walther, X Zhou, A Lopez, T Pattupara, ...
Molecular Therapy-Nucleic Acids 11, 441-454, 2018
682018
miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer
Y Pan, G Robertson, L Pedersen, E Lim, A Hernandez-Herrera, AC Rowat, ...
Oncotarget 7 (18), 25930, 2016
682016
A kinetic model explains why shorter and less affine enzyme-recruiting oligonucleotides can be more potent
L Pedersen, PH Hagedorn, MW Lindholm, M Lindow
Molecular Therapy-Nucleic Acids 3, 2014
622014
A Wnt oscillator model for somitogenesis
PB Jensen, L Pedersen, S Krishna, MH Jensen
Biophysical journal 98 (6), 943-950, 2010
602010
Independent component and pathway-based analysis of miRNA-regulated gene expression in a model of type 1 diabetes
CH Bang-Berthelsen, L Pedersen, T Fløyel, PH Hagedorn, T Gylvin, ...
BMC genomics 12, 1-11, 2011
502011
Plasma proteome analysis of patients with type 1 diabetes with diabetic nephropathy
AJ Overgaard, HG Hansen, M Lajer, L Pedersen, L Tarnow, P Rossing, ...
Proteome science 8, 1-11, 2010
492010
Expression and localization of microRNAs in perinatal rat pancreas: role of miR-21 in regulation of cholesterol metabolism
L Larsen, MW Rosenstierne, LW Gaarn, A Bagge, L Pedersen, ...
PloS one 6 (10), e25997, 2011
382011
Identifying interactions in omics data for clinical biomarker discovery using symbolic regression
NJ Christensen, S Demharter, M Machado, L Pedersen, M Salvatore, ...
Bioinformatics 38 (15), 3749-3758, 2022
232022
Finding diabetic nephropathy biomarkers in the plasma peptidome by high‐throughput magnetic bead processing and MALDI‐TOF‐MS analysis
HG Hansen, J Overgaard, M Lajer, F Hubalek, P Højrup, L Pedersen, ...
PROTEOMICS–Clinical Applications 4 (8‐9), 697-705, 2010
212010
Dickkopf1-a new player in modelling the Wnt pathway
L Pedersen, MH Jensen, S Krishna
PLoS One 6 (10), e25550, 2011
172011
Comment on “Direct Measurement of the Oscillation Frequency in an Optical-Tweezers Trap by Parametric Excitation”
L Pedersen, H Flyvbjerg
Physical Review Letters 98 (18), 189801, 2007
112007
Oligonucleotides for inducing paternal UBE3A expression
V Costa, M Hedtjärn, M Hoener, R Jagasia, MA Jensen, C Patsch, ...
US Patent 10,494,633, 2019
102019
Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatitis B infection
S Kammler, A Lopez, H Mueller, S Ottosen, L Pedersen
US Patent 10,953,034, 2021
72021
Identifying suitable target regions and analyzing off-target effects of therapeutic oligonucleotides
L Pedersen, PH Hagedorn, T Koch
Oligonucleotide-Based Therapies: Methods and Protocols, 261-282, 2019
62019
Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatitis B infection
S Kammler, A Lopez, H Mueller, S Ottosen, L Pedersen
US Patent 11,484,546, 2022
52022
Oligonucleotides for reduction of pd-l1 expression
L Pedersen, H Javanbakht, M Jackerott, S Ottosen, S Luangsay
US Patent App. 15/458,800, 2017
52017
Antisense oligonucleotides targeting ATXN3
MR Møller, HR Hudlebusch, L Pedersen, ED Funder, C Sondergaard, ...
US Patent 11,542,501, 2023
42023
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20